Catálogo
Ayuda
Construye tu portafolio aquí
Ingresa la cantidad junto a las acciones que necesitas — el portafolio se creará automáticamente.
Filtro rápido: categorías, recomendaciones, métricas fundamentales y perfiles de empresas.
Paquete inicial de dividendos
Blue chips — comprar
Líderes de crecimiento
Defensivas — baja volatilidad
| Empresa | Categoría | Precio | Δ% | Div% | Vol20 | EPS(TTM) | QoQ | EPS(SPR) | Estilo | Horizonte | Pot. | Riesgo | Recomendación | Portafolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10x Genomics (TXG) | Biotecnología | 0.00 | — | 0.0% | 0.0% | -0.59 | 0.1% | 0.0% | Crecimiento | Medio | 0 | 0 | — |
|
| Abivax (ABVX) | Biotecnología | 88.01 | -2.46% | 0.0% | 2.7% | -6.66 | -200.0% | -74.7% | Crecimiento | Medio | 20 | 85 | Vender |
|
| Alnylam Pharmaceuticals (ALNY) | Biotecnología | 224.03 | -1.43% | 0.0% | 2.4% | 6.10 | 10.6% | -25.8% | Crecimiento | Medio | 34 | 75 | Vender |
|
| Apogee Therapeutics (APGE) | Biotecnología | 135.07 | 0.00% | 0.0% | 0.0% | -4.34 | 0.0% | -6.5% | Crecimiento | Largo | 30 | 70 | Vender |
|
| Arcus Biosciences (RCUS) | Biotecnología | 18.54 | -4.24% | 0.0% | 3.0% | -3.93 | 141.2% | 0.0% | Crecimiento | Medio | 39 | 76 | Vender |
|
| Arrowhead Pharmaceuticals (ARWR) | Biotecnología | 58.02 | -0.58% | 0.0% | 2.0% | -2.24 | 2.1% | -6.3% | Crecimiento | Medio | 32 | 71 | Vender |
|
| Bio-Techne (TECH) | Biotecnología | 72.55 | -0.10% | 0.6% | 0.1% | 1.17 | 3.1% | 0.2% | Crecimiento | Medio | 61 | 40 | Comprar |
|
| BioCryst Pharmaceuticals (BCRX) | Biotecnología | 7.65 | -1.67% | 0.0% | 2.3% | -1.44 | 39.5% | 0.0% | Crecimiento | Medio | 31 | 70 | Vender |
|
| Biohaven (BHVN) | Biotecnología | 13.88 | -5.51% | 0.0% | 3.0% | -4.64 | 0.0% | -19.6% | Crecimiento | Medio | 74 | 61 | Comprar |
|
| BioMarin Pharmaceutical (BMRN) | Biotecnología | 55.95 | -1.20% | 0.0% | 1.7% | 0.38 | 29.2% | 26.7% | Crecimiento | Medio | 56 | 68 | Comprar |
|
| BioNTech (BNTX) | Biotecnología | 88.11 | -1.73% | 0.0% | 2.3% | -6.73 | -12.0% | -54.3% | Crecimiento | Medio | 26 | 76 | Vender |
|
| CAMP4 Therapeutics (CAMP) | Biotecnología | 3.30 | -2.65% | 0.0% | 3.2% | -2.23 | 37.5% | -174.3% | Crecimiento | Medio | 25 | 81 | Vender |
|
| Celcuity (CELC) | Biotecnología | 65.25 | -0.49% | 0.0% | 3.8% | -4.29 | 0.0% | -24.1% | Crecimiento | Medio | 30 | 77 | Vender |
|
| Centessa Pharmaceuticals (CNTA) | Farmacéutica | 40.50 | 0.00% | 93.8% | 0.0% | -1.78 | 0.0% | -36.8% | Crecimiento | Medio | 30 | 72 | Vender |
|
| Cidara Therapeutics (CDTX) | Biotecnología | 221.38 | 0.00% | 0.0% | 0.0% | -11.78 | 0.0% | 0.0% | Crecimiento | Medio | 20 | 80 | Vender |
|
| Corcept Therapeutics (CORT) | Biotecnología | 85.86 | -20.13% | 0.0% | 2.6% | 0.52 | 55.3% | 1383.3% | Crecimiento | Medio | 40 | 75 | Vender |
|
| Corvus Pharmaceuticals (CRVS) | Biotecnología | 10.53 | -1.13% | 0.0% | 2.6% | -0.64 | 0.0% | -19.4% | Crecimiento | Medio | 31 | 72 | Vender |
|
| CPRX (CPRX) | Salud | 31.49 | 0.00% | 0.0% | 0.0% | 1.80 | -2.1% | 15.6% | Crecimiento | Medio | 52 | 52 | Mantener |
|
| Crinetics Pharmaceuticals (CRNX) | Biotecnología | 84.95 | 0.00% | 0.0% | 0.0% | -5.05 | 134.0% | 0.0% | Crecimiento | Medio | 65 | 67 | Mantener |
|
| Definium Therapeutics (DFTX) | Biotecnología | 35.67 | -0.92% | 0.0% | 3.2% | -3.44 | 0.0% | -166.2% | Crecimiento | Medio | 39 | 73 | Vender |
|
| Dianthus Therapeutics (DNTH) | Biotecnología | 76.78 | -2.23% | 0.0% | 2.3% | -0.13 | 64.4% | 0.0% | Crecimiento | Largo | 39 | 71 | Vender |
|
| Disc Medicine (IRON) | Biotecnología | 74.51 | -0.69% | 0.0% | 8.8% | -6.60 | 0.0% | 9.9% | Crecimiento | Medio | 71 | 64 | Comprar |
|
| EyePoint Pharmaceuticals (EYPT) | Salud | 0.40 | -5.51% | 0.0% | 18.8% | -3.74 | -27.2% | -7.9% | Valor | Medio | 0 | 100 | Vender |
|
| Forte Biosciences (FBRX) | Biotecnología | 76.99 | 0.00% | 0.0% | 0.0% | -4.59 | 0.0% | 10.2% | Crecimiento | Medio | 70 | 69 | Mantener |
|
| ImmunityBio (IBIO) | Biotecnología | 0.72 | -8.44% | 0.0% | 3.9% | -0.33 | -100.0% | 42.3% | Crecimiento | Medio | 10 | 85 | Vender |
|
| Immunovant (IMVT) | Biotecnología | 28.41 | -2.37% | 0.0% | 2.3% | -2.82 | 0.0% | -19.3% | Crecimiento | Medio | 31 | 71 | Vender |
|
| Incyte (INCY) | Farmacéutica | 115.71 | -1.04% | 0.0% | 1.7% | 8.13 | 31.5% | 43.7% | Crecimiento | Medio | 67 | 41 | Comprar |
|
| Intellia Therapeutics (NTLA) | Biotecnología | 11.21 | +0.45% | 0.0% | 3.4% | -3.36 | -49.1% | -0.1% | Crecimiento | Medio | 30 | 80 | Vender |
|
| Ionis Pharmaceuticals (IONS) | Biotecnología | 42.93 | -2.23% | 0.0% | 2.2% | -3.46 | 8.9% | 0.0% | Crecimiento | Largo | 24 | 85 | Vender |
|
| Jazz Pharmaceuticals (JAZZ) | Biotecnología | 214.00 | -0.30% | 0.0% | 1.6% | 15.20 | 13.0% | -7.6% | Balanceado | Medio | 39 | 72 | Vender |
|